Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
PhishPharm - Detail
FDA Home
PhishPharm
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Title:
Tissue distribution and residue depletion of oxolinic acid in gilthead seabream (Sparus aurata) and sharpsnout sea bream (Diplodus puntazzo) following multiple in-feed dosings.
Authors:
Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi GM
Drug:
Oxolinic acid
Fish species:
Seabream, gilthead
Date:
2004
t1/2-hr:
11
Sample:
liver
Ave Weight (gm):
170
Ave Water temp (°C):
19
Water:
Saltwater
Dosage:
30 mg/kg 10 d
Route:
PO
Comments:
Displayed biphasic elimination in tissues and reached "consumer safe levels 24 h after treatment. Residues ng/mg = d1=2380, d2=640, d3=1110, d4=2660, d5=790, d6=1520, d7=1240, d8=730, d9=560, d10=290, d11=70, d12=30, d14=30,d15=20,d17=20. AUC=325 ug/h ml.
Citation:
Aquaculture 224:245-256
Link:
http://dx.doi.org/10.1016/S0044-8486(03)00213-8
Genus Species:
Sparus aurata
Drug Class:
Antibiotic-Quinolone
t1/2-detail:
11 h
Wt gm-detail:
170+/-25 g
Water temp (°C)-detail:
19 +/-1 C
Dosage-detail:
30 mg/kg for 10 d
Method:
HPLC
Authors-red:
Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi GM
-
-